Jinxin Fertility Group Limited

HKEX:1951.HK

3.53 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 1,443.7561,455.0041,333.9061,226.2511,138.228979.523859.303814.244611.844857.376791.12510.156411.838230.499165.694165.694165.69486.60286.60286.602
Cost of Revenue 860.74843.883769.582777.427673.924571.283496.061465.927394.38421.432410.269287.171221.704127.21990.1690.1690.1653.42253.42253.422
Gross Profit 583.016611.121564.324448.824464.304408.24363.242348.317217.464435.944380.851222.985190.134103.2875.53475.53475.53433.1833.1833.18
Gross Profit Ratio 0.4040.420.4230.3660.4080.4170.4230.4280.3550.5080.4810.4370.4620.4480.4560.4560.4560.3830.3830.383
Reseach & Development Expenses 10.88811.09710.64912.7364.7385.6714.987.1474.3367.5285.776.4035.5792.9962.5772.5772.577000
General & Administrative Expenses 215.694293.297188.072271.257187.596183.066144.664178.9596.31129.9581.34566.35437.08115.7773.0333.0333.0332.4732.4732.473
Selling & Marketing Expenses 86.272104.61487.24297.75353.68235.58926.12725.77815.57944.31917.915.55500000-2.29-2.29-2.29
SG&A 301.966397.911275.314369.01241.278218.655170.791204.728111.889174.26999.24566.35437.081-1.04-2.438-2.438-2.4380.1830.1830.183
Other Expenses 00000000000-0.87700000000
Operating Expenses 312.854409.008258.543502.959212.337163.856163.001161.11790.758160.336145.41593.44452.7011.9560.1390.1390.1390.1830.1830.183
Operating Income 270.162202.113278.36167.078218.288183.914187.471136.442101.239254.147275.836150.228147.47457.76635.45435.45435.45427.62727.62727.627
Operating Income Ratio 0.1870.1390.2090.0550.1920.1880.2180.1680.1650.2960.3490.2940.3580.2510.2140.2140.2140.3190.3190.319
Total Other Income Expenses Net -4.406-16.380.174-146.41415.37267.22619.31660.2551.20349.372-31.455-15.749-5.36511.38124.94224.94224.942-0.291-0.291-0.291
Income Before Tax 265.756185.733278.535-79.336233.66251.14206.787196.692152.442303.519244.381134.479142.10969.14760.39660.39660.39627.33627.33627.336
Income Before Tax Ratio 0.1840.1280.209-0.0650.2050.2560.2410.2420.2490.3540.3090.2640.3450.30.3650.3650.3650.3160.3160.316
Income Tax Expense 75.44362.55154.7349.68846.06360.07444.15659.67828.9660.866.42330.36934.09516.11610.75810.75810.7581.4241.4241.424
Net Income 189.682121.16223.563-69.025190.149184.253155.648135.529116.093239.46170.16399.14367.45753.03149.63849.63849.63825.91325.91325.913
Net Income Ratio 0.1310.0830.168-0.0560.1670.1880.1810.1660.190.2790.2150.1940.1640.230.30.30.30.2990.2990.299
EPS 0.070.0440.078-0.0280.0690.0740.060.050.0480.10.080.0550.140.0220.0210.0210.0210.0110.0110.011
EPS Diluted 0.070.0440.082-0.0260.0730.0730.0630.0560.0480.0990.0850.0560.140.0220.0210.0210.0210.0110.0110.011
EBITDA 370.167311.925370.098176.423299.792259.907234.173188.122143.787295.14314.154168.526165.60868.33444.29144.29144.29131.19831.19831.198
EBITDA Ratio 0.2560.2140.2770.1440.2630.2650.2730.2310.2350.3440.3970.330.4020.2960.2670.2670.2670.360.360.36